［原著論文］
Sugai T, Suzuki Y, Yamazaki M, Sugawara N, Yasui-Furukori N, Shimoda K,
Mori T, Ozeki Y, Matsuda H, Okamoto K, Sagae T, Someya T: Lower prolactin
levels in patients treated with aripiprazole regardless of antipsychotic
monopharamacy or polypharmacy. J Clin Psychopharmacol 40(1): 14-17, 2020.
Sugimoto A, Suzuki Y, Orime N, Hayashi T, Egawa J, Sugai T, Inoue Y, Someya
T: Non-linear pharmacokinetics of atomoxetine in adult Japanese patients
with ADHD. J Atten Disord 24(3): 490-493, 2020.
Hayashi T, Akikawa R, Kawasaki K, Egawa J, Minamimoto T, Kobayashi K, Kato
S, Hori Y, Nagai Y, Iijima A, Someya T, Hasagawa I: Macaques exhibit implicit
gaze bias anticipating others’ false-belief-driven actions via medial prefrontal
cortex. Cell Rep 30(13): 4433-4444, 2020.
Hoya S, Watanabe Y, Nunokawa A, Otsuka I, Shibuya M, Igeta H, Hishimoto
A, Someya T: Whole-exome sequencing in a family with a monozygotic twin
pair concordant for schizophrenia and a follow-up case-control study of
identified de-novo variants. Psychiatr Genet 30(2): 60-63, 2020.
Ono S, Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, Matsuda
H, Sugawara N, Yasui-Furukori N, Okamoto K, Sagae T, Someya T: Association
of selected antipsychotics on the triglyceride levels in patients with
schizophrenia in inpatient and outpatient settings. Clin Neuropsychopharmacol
Ther 11: 15-22, 2020.
Sugai T, Suzuki Y, Yamazaki M, Sugawara N, Yasui-Furukori N, Shimoda K,
Mori T, Ozeki Y, Watanabe Y, Matsuda H, Okamoto K, Sagae T, Someya T: The
relationship between schizophrenia patients’ attitudes towards physical
health and the prevalence of metabolic syndrome. Clin Neuropsychopharmacol
Ther 11: 23-34, 2020.
Ishizuka K, Yoshida T, Kawabata T, Imai A, Mori H, Kimura H, Inada T, Okahisa
Y, Egawa J, Usami M, Kushima I, Morikawa M, Okada T, Ikeda M, Branko A,
Mori D, Someya T, Iwata M, Ozaki N: Functional characterization of rare
NRXN1 variants identified in autism spectrum disorders and schizophrenia.
J Neurodev Disord 12(1): 25, 2020.
Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda
H, Suzuki Y, Ozeki Y, Okamoto K, Sagae T, Someya T: Predictive utility
of body mass index for metabolic syndrome among patients with schizophrenia
in Japan. Neuropsychiat Dis Treat 16: 2229-2236, 2020.
Nawa Y, Kimura H, Mori D, Kato H, Toyama M, Furuta S, Yu Y, Ishizuka K,
Kushima I, Aleksic B, Arioka Y, Morikawa M, Okada T, Inada T, Kaibuchi
K, Ikeda M, Iwata N, Suzuki M, Okahisa Y, Egawa J, Someya T, Nishimura
F, Sasaki T, Ozaki N: Rare single-nucleotide DAB1 variants and their contribution
to schizophrenia and autism spectrum disorder susceptibility. Hum Genome
Var 7(1): 37, 2020.
Kato H, Kushima I, Mori D, Yoshimi A, Aleksic B, Nawa Y, Toyama M, Furuta
S, Yu Y, Ishizuka K, Kimura H, Arioka Y, Tsujimura K, Morikawa M, Okada
T, Inada T, Shinjo K, Kondo Y, Kaibuchi K, Funabiki Y, Kimura R, Suzuki
T, Yamakawa K, Ikeda M, Iwata N, Takahashi T, Suzuki M, Okahisa Y, Takaki
M, Egawa J, Someya T, Ozaki N: Rare genetic variants in the gene encoding
histone lysine demethylase 4C (KDM4C) and their contributions to susceptibility
to schizophrenia and autism spectrum disorder. Transl Psychiatry 10(1):
421, 2020.
Motegi T, Watanabe Y, Fukui N, Ogawa M, Hashijiri K, Tsuboya R, Sugai T,
Egawa J, Araki R, Haino K, Yamaguchi M, Nishijima K, Enomoto T, Someya
T: Depression, anxiety and primiparity are negatively associated with mother–infant
bonding in Japanese mothers. Neuropsychiat Dis Treat 16: 3117-3122, 2020.
河内泉, 須貝拓朗, 鈴木利哉, 土田正則, 齋藤昭彦, 佐藤昇, 染矢俊幸: 新潟大学におけるCOVID-19パンデミック下のオンライン医学教育 -未来教育への道すじ-. 医学教育 51(3): 231-233, 2020.
